ImmunoPrecise Antibodies Ltd.

The momentum for this stock is not very good. ImmunoPrecise Antibodies Ltd. is not a good value stock. ImmunoPrecise Antibodies Ltd. has good growth characteristics. ImmunoPrecise Antibodies Ltd. is not very popular among insiders. ImmunoPrecise Antibodies Ltd. is a mediocre stock to choose.
Log in to see more information.

News

ImmunoPrecise Antibodies (NASDAQ:IPA)  Shares Down 2.4%
ImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.4%

Zolmax ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA - Get Free Report) shares dropped 2.4% during mid-day trading on Monday . The stock traded as low as $0.64 and last traded at $0.65. Approximately 33,302...\n more…

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Down 2.4%
ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Down 2.4%

Ticker Report Shares of ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA - Get Free Report) fell 2.4% on Monday . The stock traded as low as $0.64 and last traded at $0.65. 33,302 shares traded hands during mid-day...\n more…

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024

Business Wire IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the Company or IPA) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today announced that it will host a...\n more…

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago. These figures are...\n more…

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York

Business Wire ImmunoPrecise Antibodies Ltd. (the Company or IPA) (NASDAQ: IPA), is pleased to announce that it will be attending H.C. Wainwright's 26th Annual Global Investment Conference (the 'Global Investment...\n more…

ImmunoPrecise Antibodies receives non-compliance notice from Nasdaq
ImmunoPrecise Antibodies receives non-compliance notice from Nasdaq

Seeking Alpha - Healthcare ImmunoPrecise Antibodies receives non-compliance notice from Nasdaq...\n more…